Your browser doesn't support javascript.
loading
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
Echeverría, Patricia; Bonjoch, Anna; Puig, Jordi; Moltó, José; Paredes, Roger; Sirera, Guillem; Ornelas, Arelly; Pérez-Álvarez, Nuria; Clotet, Bonaventura; Negredo, Eugènia.
Afiliación
  • Echeverría P; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
  • Bonjoch A; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
  • Puig J; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
  • Moltó J; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
  • Paredes R; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain ; IrsiCaixa AIDS Research Institute-HIVACAT, Barcelona, Spain.
  • Sirera G; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
  • Ornelas A; Department of Econometrics, Statistics and Spanish Economy; University of Barcelona, Barcelona, Spain.
  • Pérez-Álvarez N; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain ; Statistics and Operations Research Department, Universitat Politècnica de Catalunya, Barcelona, Spain.
  • Clotet B; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain ; IrsiCaixa AIDS Research Institute-HIVACAT, Barcelona, Spain.
  • Negredo E; Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
PLoS One ; 9(2): e84676, 2014.
Article en En | MEDLINE | ID: mdl-24503952
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridazinas / Infecciones por VIH / Inhibidores de la Proteasa del VIH Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridazinas / Infecciones por VIH / Inhibidores de la Proteasa del VIH Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: España